NCT06881446
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Zhongda Hospital Nanjing, Jiangsu, China
Clinical trial condition
Liver Neoplasms
Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.
1,743 public trials
464 recruiting studies
Liver Neoplasms trial results
NCT04118114
- Conditions
- Adenocarcinoma, Advanced Solid Tumor, Carcinoma, +15 more
- Locations
-
- National Cancer Center Singapore Singapore
NCT06261047
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Jinbo Yue Jinan, Shandong, China
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Banner MD Anderson Cancer Center ( Site 0026) Gilbert, Arizona, United States
- The University of Arizona Cancer Center - North Campus ( Site 0039) Tucson, Arizona, United States
- City of Hope Medical Center ( Site 0027) Duarte, California, United States
- Smilow Cancer Hospital at Yale New Haven ( Site 0042) New Haven, Connecticut, United States
NCT02366286
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +20 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Completed
Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis
NCT02551250
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- Seoul St.Mary's Hospital Seoul, South Korea
- Korean University Guro Hospital Seoul, South Korea
- Samsung Medical Center Seoul, South Korea
- Seoul National University Hospital Seoul, South Korea
NCT05625893
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
NCT01899261
- Conditions
- Adenocarcinoma, Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, +12 more
- Locations
-
- Albert Einstein College of Medicine The Bronx, New York, United States
Completed
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC
NCT05332496
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Gao-Jun Teng Nanjing, China
- Zheng-Gang Ren Nanjing, China
Completed
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC
NCT05332821
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Gao-Jun Teng Nanjing, China
- Zheng-Gang Ren Shanghai, China